de Hora, M. R., Heather, N. L., Patel, T., Bresnahan, L. G., Webster, D., & Hofman, P. L. (2020). Measurement of 17-Hydroxyprogesterone by LCMSMS Improves Newborn Screening for CAH Due to 21-Hydroxylase Deficiency in New Zealand. Int J Neonatal Screen.

de Hora, Mark R., Natasha L. Heather, Tejal Patel, Lauren G. Bresnahan, Dianne Webster, and Paul L. Hofman. "Measurement of 17-Hydroxyprogesterone By LCMSMS Improves Newborn Screening for CAH Due to 21-Hydroxylase Deficiency in New Zealand." Int J Neonatal Screen 2020.

de Hora, Mark R., et al. "Measurement of 17-Hydroxyprogesterone By LCMSMS Improves Newborn Screening for CAH Due to 21-Hydroxylase Deficiency in New Zealand." Int J Neonatal Screen 2020.